Lazzari, C., Gregorc, V., & Santarpia, M. (2019). Impact of clinical features of epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer (NSCLC) patients on osimertinib efficacy. J Thorac Dis.
Chicago Style citaatLazzari, Chiara, Vanesa Gregorc, en Mariacarmela Santarpia. "Impact of Clinical Features of Epidermal Growth Factor Receptor (EGFR)-mutated Non-small Cell Lung Cancer (NSCLC) Patients On Osimertinib Efficacy." J Thorac Dis 2019.
MLA citatieLazzari, Chiara, Vanesa Gregorc, en Mariacarmela Santarpia. "Impact of Clinical Features of Epidermal Growth Factor Receptor (EGFR)-mutated Non-small Cell Lung Cancer (NSCLC) Patients On Osimertinib Efficacy." J Thorac Dis 2019.
Let op: Deze citaties zijn niet altijd 100% accuraat.